|
Re: CVOTs on the Horizon
|
2
|
Resverlogix Corp.
|
Oct 02, 2018 12:28PM
|
|
Re: CVOTs on the Horizon
|
1
|
Resverlogix Corp.
|
Oct 01, 2018 04:58PM
|
|
Re: Resverlogix H2 2018 events
|
1
|
Resverlogix Corp.
|
Sep 29, 2018 11:37AM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
5
|
Resverlogix Corp.
|
Sep 25, 2018 10:10AM
|
|
Saw these articles that might be relevant to us,...
|
4
|
Resverlogix Corp.
|
Sep 20, 2018 11:26AM
|
|
Re: RVX AGM Q&A, post AGM-huddle, impressions
|
3
|
Resverlogix Corp.
|
Sep 20, 2018 09:48AM
|
|
Re: RVX AGM Q&A, post AGM-huddle, impressions
|
5
|
Resverlogix Corp.
|
Sep 19, 2018 08:47AM
|
|
Re: I'm glad the SSRA issue has finally been put to bed....
|
1
|
Resverlogix Corp.
|
Sep 16, 2018 09:11PM
|
|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
5
|
Resverlogix Corp.
|
Sep 15, 2018 11:50AM
|
|
Re: Someone say that the sky is falling down?
|
1
|
Resverlogix Corp.
|
Sep 12, 2018 11:51AM
|
|
Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension
|
4
|
Resverlogix Corp.
|
Sep 04, 2018 12:28AM
|
|
Re: Perspective on # MACE events and timeline to top-line
|
8
|
Resverlogix Corp.
|
Sep 01, 2018 12:30PM
|
